New Key Statistics Module, Z-Score and F-Score
NAS:REGN Key Ratios
Market Cap $ M | 132,174.51 |
Enterprise Value $ M | 125,079.03 |
P/E(ttm) | 31.76 |
PE Ratio without NRI | 28.90 |
Forward PE Ratio | 26.60 |
Price/Book | 4.69 |
Price/Sales | 10.19 |
Price/Free Cash Flow | 43.06 |
Price/Owner Earnings | 52.76 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 13,489.00 |
EPS (TTM) $ | 37.76 |
Beneish M-Score | -2.29 |
10-y EBITDA Growth Rate % | 24.90 |
5-y EBITDA Growth Rate % | 17.70 |
y-y EBITDA Growth Rate % | -3.20 |
EV-to-EBIT | 26.91 |
EV-to-EBITDA | 24.52 |
PEG | 1.63 |
Shares Outstanding M | 110.23 |
Net Margin (%) | 32.04 |
Operating Margin % | 30.14 |
Pre-tax Margin (%) | 34.01 |
Quick Ratio | 4.62 |
Current Ratio | 5.44 |
ROA % (ttm) | 12.99 |
ROE % (ttm) | 16.61 |
ROIC % (ttm) | 18.87 |
Dividend Yield % | -- |
Altman Z-Score | 12.52 |
REGN Number of Guru Trades
REGN Volume of Guru Trades
Gurus Latest Trades with NAS:REGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:REGN is held by these investors
Total 6
Regeneron Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:REGN
Total 0- 1